NO873562D0 - Fremgangsmaate for fremstilling av et farmasoeytisk preparat med forbedret absorpsjon av sulindac. - Google Patents

Fremgangsmaate for fremstilling av et farmasoeytisk preparat med forbedret absorpsjon av sulindac.

Info

Publication number
NO873562D0
NO873562D0 NO873562A NO873562A NO873562D0 NO 873562 D0 NO873562 D0 NO 873562D0 NO 873562 A NO873562 A NO 873562A NO 873562 A NO873562 A NO 873562A NO 873562 D0 NO873562 D0 NO 873562D0
Authority
NO
Norway
Prior art keywords
preparation
sulindac
absorption
procedure
improved
Prior art date
Application number
NO873562A
Other languages
English (en)
Other versions
NO873562L (no
Inventor
Joseph L O'neill
Eugene J Dehner
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO873562D0 publication Critical patent/NO873562D0/no
Publication of NO873562L publication Critical patent/NO873562L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
NO873562A 1986-08-25 1987-08-24 Hurtig-absorberende og -virkende kombinasjon av sulindac eller natriumsulindac og en base. NO873562L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/900,201 US4704405A (en) 1986-08-25 1986-08-25 Rapid acting combination of sodium sulindac and a base

Publications (2)

Publication Number Publication Date
NO873562D0 true NO873562D0 (no) 1987-08-24
NO873562L NO873562L (no) 1988-02-26

Family

ID=25412127

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873562A NO873562L (no) 1986-08-25 1987-08-24 Hurtig-absorberende og -virkende kombinasjon av sulindac eller natriumsulindac og en base.

Country Status (13)

Country Link
US (1) US4704405A (no)
EP (1) EP0259990A1 (no)
JP (1) JPS6388122A (no)
KR (1) KR880002515A (no)
CN (1) CN87105828A (no)
AU (2) AU4028772A (no)
DK (1) DK440587A (no)
FI (1) FI873550A (no)
HU (1) HUT44925A (no)
IL (1) IL83579A0 (no)
NO (1) NO873562L (no)
PT (1) PT85566B (no)
ZA (1) ZA876253B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977181A (en) * 1987-12-18 1990-12-11 Ciba-Geigy Corporation Tromethamine salt of 1-methyl-beta-oxo-alpha-(phenylcarbamoyl)-2-pyrrolepropionitrile
GR880100839A (el) * 1988-12-15 1994-03-31 Ciba Geigy Αλας τρομε?αμίνης του 1-με?ύλ-Β-ΟΞΟ-Α-(φαινυλοκαρβομουλό)-2-πυρρολοπροπιονιτριλίου.
KR920002148A (ko) * 1990-07-03 1992-02-28 안드레아 엘. 콜비 비스테로이드계 소염제에 의해 유발된 위장 증상을 완화시키기 위한 약제 조성물 및 이를 완화시키는 방법
US5183829A (en) * 1991-09-27 1993-02-02 Applied Analytical Industries, Inc. Oral liquid compositions of non-steroidal anti-inflammatory drugs
US5288507A (en) * 1992-07-29 1994-02-22 Merck & Co., Inc. Ibuprofen antacid combinations
US6365180B1 (en) 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
ATE429210T1 (de) 1998-01-20 2009-05-15 Applied Analytical Ind Inc Orale flüssige zusammensetzungen
KR100385366B1 (ko) * 2001-03-05 2003-05-27 부광약품 주식회사 생체이용율을 개선한 실리마린 제제 조성물
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
US20030152622A1 (en) * 2001-10-25 2003-08-14 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral diuretic
KR20030029067A (ko) * 2003-02-10 2003-04-11 정진욱 토탄과 하수종말처리장 슬라지 폐기물을 배합한 가래 탄과그 제조방법.
WO2005004763A1 (en) * 2003-07-01 2005-01-20 Pharmacia & Upjohn Company Llc. Diffusion layer modulated solids
ITMI20032523A1 (it) * 2003-12-19 2005-06-20 Acraf Forma di dosaggio per uso orale comprendente un farmaco
US20070093457A1 (en) * 2004-02-11 2007-04-26 Nadir Arber Compositions for treatment of cancer and inflammation with curcumin and at least one nsaid
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
JP2008500288A (ja) 2004-05-28 2008-01-10 イメイジノット ピーティーワイ エルティーディー 経口治療用化合物の供給系
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
KR100576332B1 (ko) * 2004-07-16 2006-05-03 강승우 신규한 글라이세리드 유도체 및 이를 포함하는 통증완화용조성물
KR100621119B1 (ko) * 2005-07-28 2006-09-07 (주)삼창뉴텍 고체 화석연료의 고화 방법
EP3449928A1 (en) 2005-11-28 2019-03-06 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US9289409B2 (en) * 2008-04-18 2016-03-22 Warsaw Orthopedic, Inc. Sulindac formulations in a biodegradable material
US20100098746A1 (en) * 2008-10-20 2010-04-22 Warsaw Orthopedic, Inc. Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone
WO2014060855A1 (en) 2012-10-16 2014-04-24 Wockhardt Limited Pharmaceutical compositions of diclofenac or salts thereof
WO2014060856A1 (en) 2012-10-16 2014-04-24 Wockhardt Limited Pharmaceutical compositions of diclofenac or salts thereof
WO2014060857A1 (en) 2012-10-19 2014-04-24 Wockhardt Limited Pharmaceutical compositions of diclofenac or salts thereof
CN109223740A (zh) * 2016-12-26 2019-01-18 云南中医学院 一种氨丁三醇有机酸盐的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE134672C (no) *
US3654349A (en) * 1970-05-01 1972-04-04 Merck & Co Inc Substituted indenyl acetic acids
HU185926B (en) * 1979-09-27 1985-04-28 Agostne Kahan Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
US4402979A (en) * 1980-03-21 1983-09-06 Merck & Co., Inc. & Laboratories Ophthalmic formulations of 5-fluoro-2-methyl-1-(p-methylthiobenzylidene)-3-indenylacetic acid
US4307114A (en) * 1980-06-19 1981-12-22 Ayerst, Mckenna & Harrison, Inc. Aldose reductase inhibition by (Z)-5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic acid

Also Published As

Publication number Publication date
ZA876253B (en) 1988-04-27
PT85566B (en) 1989-11-09
US4704405A (en) 1987-11-03
NO873562L (no) 1988-02-26
AU7715687A (en) 1988-02-25
FI873550A0 (fi) 1987-08-17
PT85566A (en) 1987-09-01
KR880002515A (ko) 1988-05-09
DK440587D0 (da) 1987-08-24
JPS6388122A (ja) 1988-04-19
EP0259990A1 (en) 1988-03-16
FI873550A (fi) 1988-02-26
CN87105828A (zh) 1988-04-27
AU4028772A (en) 1973-09-27
IL83579A0 (en) 1988-01-31
HUT44925A (en) 1988-05-30
DK440587A (da) 1988-02-26

Similar Documents

Publication Publication Date Title
NO873562D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat med forbedret absorpsjon av sulindac.
NO871790L (no) Fremgangsmaate for fremstilling av et oralt farmasoeytisk preparat.
NO870579L (no) Fremgangsmaate for fremstilling av indolizin-derivater.
NO892936L (no) Fremgangsmaate for fremstilling av furanderivater.
NO890970L (no) Fremgangsmaate for fremstilling av cykliske sulfater.
NO884052D0 (no) Fremgangsmaate for fremstilling av et terapeutisk preparat.
NO885454D0 (no) Fremgangsmaate for fremstilling av triklormonosilan.
NO870368D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat med langvarig virkning.
NO894210L (no) Fremgangsmaate for fremstilling av kinolyloxazol-2-oner.
NO894649D0 (no) Fremgangsmaate for fremstilling av (s)-alfa-ethyl-2-oxo-1-pyrrolidinacetamid.
NO870866D0 (no) Fremgangsmaate for fremstilling av et terapeutisk kombinasjonspreparat.
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
NO895032L (no) Fremgangsmaate for fremstilling av 2-benzotiazoliner.
NO892204D0 (no) Fremgangsmaate for fremstilling av imidazokinoxalin-forbindelser.
NO890159L (no) Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler.
NO891588L (no) Fremgangsmaate for fremstilling av fosfonoalkylpurinderivater.
NO873727D0 (no) Fremgangsmaate for fremstilling av benzoxazoninforbindelser med terapeutisk aktivitet.
AR240017A1 (es) Procedimiento de preparacion de una composicion farmaceutica para absorcion percutanea.
NO891574D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
NO895040L (no) Fremgangsmaate for fremstilling av polyhydroxybenzyloxypropanolaminer.
NO874199D0 (no) Fremgangsmaate for fremstilling av imidazo-pyridinonderivater.
NO873571D0 (no) Fremgangsmaate for fremstilling av et terapeutisk virksomt preparat.
NO894707L (no) Fremgangsmaate for fremstilling av benzoksazinderivater.
NO874698D0 (no) Fremgangsmaate for fremstilling av 2-guanidinothiazolderivater.
NO892813D0 (no) Fremgangsmaate til fremstilling av l-alanyl-l-prolin-derivater.